Bronchitis Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Mar 2019| TMR1462A| Transparency

Report Highlights

Global Bronchitis Treatment market: Overview

This report analyzes the current and future scenario of the global bronchitis treatment market. Rise in geriatric population, high incidence of bronchitis, and increase in cigarette smoking patient pool are major drivers of the global market.

The global bronchitis treatment market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to segments based on type, drug class, distribution channel, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global bronchitis treatment market.

Global Bronchitis Treatment Market: Key Segments

The global bronchitis treatment market has been segmented based on type, drug class, distribution channel, and region. Furthermore, in terms of type, the market has been divided into chronic bronchitis and acute bronchitis. The chronic bronchitis segment is likely to account for a leading share of the global market during the forecast period owing to high morbidity and mortality rate. Based on drug class, the bronchitis treatment market has been classified into antibiotics, anti-inflammatory drugs, bronchodilators, and mucolytics. In terms of distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment held a significant share of the market in 2017 due to a rise in the sale of over-the-counter bronchitis therapeutics. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Bronchitis Treatment Market: Regional Outlook

In terms of region, the global bronchitis treatment market has been segmented into five major regions and key countries/sub-regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global bronchitis treatment market based on various attributes such as company overview, financial overview, type portfolio, business strategies, and recent developments. Key players in the global bronchitis treatment market are AstraZeneca, Novartis AG, GlaxoSmithKline plc, Dr. Reddy's Laboratories Ltd., Melinta Therapeutics, Sanofi Aventis, and Boehringer Ingelheim International GmbH.

The global bronchitis treatment market has been segmented as given below:

Global Bronchitis Treatment Market, by Type
Acute Bronchitis
Chronic Bronchitis
Global Bronchitis Treatment Market, by Drug Class
Antibiotics
Anti-inflammatory Drugs
Bronchodilators
Mucolytics
Global Bronchitis Treatment Market, by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Bronchitis Treatment Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

  • Table 1 : Pipeline Analysis
  • Table 2 : Global Bronchitis Treatment Market Value (US$ Mn) Forecast, by Type, 2016–2026
  • Table 3 : Global Bronchitis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 4 : Global Bronchitis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 5 : Global Bronchitis Treatment Market Value (US$ Mn) Forecast, by Region, 2016–2026
  • Table 6 : North America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Country, 2016–2026
  • Table 7 : North America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Type, 2016–2026
  • Table 8 : North America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 9 : North America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 10 : Europe Bronchitis Treatment Market Value (US$ Mn) Forecast, by Country/Region 2016–2026
  • Table 11 : Europe Bronchitis Treatment Market Value (US$ Mn) Forecast, by Type, 2016–2026
  • Table 12 : Europe Bronchitis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 13 : Europe Bronchitis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 14 : Asia Pacific Bronchitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region 2016–2026
  • Table 15 : Asia Pacific Bronchitis Treatment Market Value (US$ Mn) Forecast, by Type, 2016–2026
  • Table 16 : Asia Pacific Bronchitis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 17 : Asia Pacific Bronchitis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 18 : Latin America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 19 : Latin America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Type, 2016–2026
  • Table 20 : Latin America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 21 : Latin America Bronchitis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 22 : Middle East & Africa Bronchitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region,
  • Table 23 : Middle East & Africa Bronchitis Treatment Market Value (US$ Mn) Forecast, by Type, 2016–2026
  • Table 24 : Middle East & Africa Bronchitis Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 25 : Middle East & Africa Bronchitis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Figure 1 : Global Bronchitis Treatment Market Value (US$ Mn) and Distribution, by Region, 2018 and 2026
  • Figure 2 : Global Bronchitis Treatment Market Revenue Projection (US$ Mn), 2016–2026
  • Figure 3 : Global Bronchitis Treatment Market Value Share, by Type, 2017
  • Figure 4 : Global Bronchitis Treatment Market Value Share, by Drug Class, 2017
  • Figure 5 : Global Bronchitis Treatment Market Value Share, by Region, 2017
  • Figure 6 : Global Bronchitis Treatment Market Value Share, by Distribution Channel, 2017
  • Figure 7 : Global Bronchitis Treatment Market Value Share Analysis by Type, 2017 and 2026
  • Figure 8 : Global Bronchitis Treatment Market Attractiveness, by Type, 2018–2026
  • Figure 9 : Global Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Chronic Bronchitis, 2016–2026
  • Figure 10 : Global Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Acute Bronchitis, 2016–2026
  • Figure 11 : Global Bronchitis Treatment Market Value Share Analysis by Drug Class, 2017 and 2026
  • Figure 12 : Global Bronchitis Treatment Market Attractiveness, by Drug Class, 2018–2026
  • Figure 13 : Global Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Antibiotics, 2016–2026
  • Figure 14 : Global Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Anti-Inflammatory Drugs, 2016–2026
  • Figure 15 : Global Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Bronchodilators, 2016–2026
  • Figure 16 : Global Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Mucolytics, 2016–2026
  • Figure 17 : Global Bronchitis Treatment Market Value Share, by Distribution Channel, 2017 and 2026
  • Figure 18 : Global Bronchitis Treatment Market Attractiveness, by Distribution Channel, 2018–2026
  • Figure 19 : Global Bronchitis Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacies, 2016–2026
  • Figure 20 : Global Bronchitis Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2016–2026
  • Figure 21 : Global Bronchitis Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Pharmacies, 2016-2026
  • Figure 22 : Global Bronchitis Treatment Market Value Share, by Region, 2016 and 2025
  • Figure 23 : Global Bronchitis Treatment Market Attractiveness, by Region, 2018–2026
  • Figure 24 : North America Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
  • Figure 25 : North America Bronchitis Treatment Market Value Share Analysis, by Country, 2017 and 2026
  • Figure 26 : North America Bronchitis Treatment Market Attractiveness Analysis, by Country, 2018-2026
  • Figure 27 : North America Bronchitis Treatment Market Value Share Analysis, by Type, 2017 and 2026
  • Figure 28 : North America Bronchitis Treatment Market Value Share Analysis, by Drug Class, 2017 and 2026
  • Figure 29 : North America Bronchitis Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 30 : North America Bronchitis Treatment Market Attractiveness Analysis, by Type, 2018–2026
  • Figure 31 : North America Bronchitis Treatment Market Attractiveness Analysis, by Drug Class, 2018–2026
  • Figure 32 : North America Bronchitis Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 33 : Europe Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
  • Figure 34 : Europe Bronchitis Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 35 : Europe Bronchitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 36 : Europe Bronchitis Treatment Market Value Share Analysis, by Type, 2017 and 2026
  • Figure 37 : Europe Bronchitis Treatment Market Value Share Analysis, by Drug Class, 2017 and 2026
  • Figure 38 : Europe Bronchitis Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 39 : Europe Bronchitis Treatment Market Attractiveness Analysis, by Type, 2018–2026
  • Figure 40 : Europe Bronchitis Treatment Market Attractiveness Analysis, by Drug Class, 2018–2026
  • Figure 41 : Europe Bronchitis Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 42 : Asia Pacific Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 43 : Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 44 : Asia Pacific Bronchitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 45 : Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Type, 2017 and 2026
  • Figure 46 : Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Drug Class, 2017 and 2026
  • Figure 47 : Asia Pacific Bronchitis Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 48 : Asia Pacific Bronchitis Treatment Market Attractiveness Analysis, by Type, 2018–2026
  • Figure 49 : Asia Pacific Bronchitis Treatment Market Attractiveness Analysis, by Drug Class, 2018–2026
  • Figure 50 : Asia Pacific Bronchitis Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 51 : Latin America Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 52 : Latin America Bronchitis Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 53 : Latin America Bronchitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 54 : Latin America Bronchitis Treatment Market Value Share Analysis, by Type, 2017 and 2026
  • Figure 55 : Latin America Bronchitis Treatment Market Value Share Analysis, by Drug Class, 2017 and 2026
  • Figure 56 : Latin America Bronchitis Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 57 : Latin America Bronchitis Treatment Market Attractiveness Analysis, by Type, 2018–2026
  • Figure 58 : Latin America Bronchitis Treatment Market Attractiveness Analysis, by Drug Class, 2018–2026
  • Figure 59 : Latin America Bronchitis Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 60 : Middle East & Africa Bronchitis Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 61 : Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 62 : Middle East & Africa Bronchitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
  • Figure 63 : Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Type, 2017 and 2026
  • Figure 64 : Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Drug Class, 2017 and 2026
  • Figure 65 : Middle East & Africa Bronchitis Treatment Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 66 : Middle East & Africa Bronchitis Treatment Market Attractiveness Analysis, by Type, 2018–2026
  • Figure 67 : Middle East & Africa Bronchitis Treatment Market Attractiveness Analysis, by Drug Class, 2018–2026
  • Figure 68 : Middle East & Africa Bronchitis Treatment Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 69 : Global Bronchitis Treatment Market Share, by Company, 2017
  • Figure 70 : AstraZeneca Breakdown of Net Sales (%), by Region, 2017
  • Figure 71 : AstraZeneca R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 72 : AstraZeneca Breakdown of Net Sales (%), by Product Segment, 2017
  • Figure 73 : Boehringer Ingelheim International GmbH, Human Pharmaceuticals Business Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 74 : Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Region, 2017
  • Figure 75 : Boehringer Ingelheim International GmbH R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 76 : Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Business Segment, 2017
  • Figure 77 : GlaxoSmithKline plc Respiratory Business Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 78 : GlaxoSmithKline plc Breakdown of Net Sales (%), by Region, 2017
  • Figure 80 : GlaxoSmithKline plc Breakdown of Net Sales (%), by Business Segment, 2017
  • Figure 81 : Novartis AG COPD Portfolio Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 82 : Novartis AG Breakdown of Net Sales (%), by Country, 2017
  • Figure 83 : Novartis AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 84 : Novartis AG Breakdown of Net Sales (%), by Business Segment, 2017
  • Figure 85 : Melinta Therapeutics Respiratory Medicine Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 86 : Melinta Therapeutics Breakdown of Net Sales (%), by Region, 2017
  • Figure 87 : Melinta Therapeutics R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 88 : Melinta Therapeutics Breakdown of Net Sales (%), by Business Segment, 2017
  • Figure 89 : Dr Reddy's Laboratories Ltd., Ltd Pharmaceuticals Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 90 : Dr Reddy's Laboratories Ltd., Breakdown of Net Sales (%), by Region, 2017
  • Figure 91 : Dr Reddy's Laboratories Ltd., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 92 : Dr Reddy's Laboratories Ltd., Breakdown of Net Sales (%), by Product Segment, 2017
  • Figure 93 : Sanofi S.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 94 : Sanofi S.A. Breakdown of Net Sales (%), by Region, 2017
  • Figure 95 : Sanofi S.A. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
  • Figure 96 : Sanofi S.A. Breakdown of Net Sales (%), by Therapeutics Area, 2017

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report